top of page
Search
All Posts
What are MPNs?
Diagnosed with MPN?
Living with MPNs
Women
Teens & Children
Events
MPN News
MPN Stories
Clinical Trials
Worldwide Day
Wellbeing
Dietary Main Course
You Tube Channel
Dietary Breakfast
Webinars
Global MPN Symposium
Sierra Oncology Signs Exclusive Global In-Licensing Agreement with AstraZeneca for Novel BET Inhibit
MPN NEWS
Peter Löffelhardt
May 27, 2023
Pelabresib (CPI-0610) Monotherapy in Patients with Myelofibrosis - Update
MPN NEWS
Peter Löffelhardt
May 27, 2023
Momelotinib: an emerging treatment for myelofibrosis patients with anemia
MPN NEWS
Peter Löffelhardt
May 27, 2023
Sierra Oncology Announces Momelotinib Achieved Statistically Significant Benefit on Symptoms, Anemia
MPN NEWS
Peter Löffelhardt
May 27, 2023
Canadian MPN Research Foundation Announces Launch of MPN Genie® App FOR IMMEDIATE RELEASE
MPN NEWS
Peter Löffelhardt
May 27, 2023
NCCN Recommends Ropeginterferon Alfa-2b in Clinical Practice Guidelines Update
MPN NEWS
Peter Löffelhardt
May 27, 2023
Feeling lost in a world of unfamiliar words and concepts?
DIAGNOSED WITH MPN?
Peter Löffelhardt
May 18, 2023
Essential Thrombocythaemia (ET)
WHAT ARE MPNS?
Peter Löffelhardt
May 17, 2023
40
41
42
43
44
Home
bottom of page